AI-powered breast cancer screening wearable enters final trials

Lord's Mark Industries has moved its AI-powered, radiation-free breast cancer screening wearable into the final clinical trial stage across the USA, Great Britain and Europe. The device uses thermal sensors and artificial intelligence to detect abnormal temperature patterns. The company is targeting commercial placement from April 2027, subject to successful trials and regulatory approvals.